Production (Stage)
Acumen Pharmaceuticals, Inc.
ABOS
$1.02
-$0.01-0.97%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -28.80M | -37.15M | -29.77M | -20.54M | -14.87M |
| Total Depreciation and Amortization | 45.00K | 44.00K | 45.00K | 45.00K | 44.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.99M | 1.67M | 1.39M | 182.00K | 1.04M |
| Change in Net Operating Assets | -7.36M | 8.22M | 3.73M | 3.77M | -4.07M |
| Cash from Operations | -34.12M | -27.22M | -24.60M | -16.55M | -17.86M |
| Capital Expenditure | -79.00K | 0.00 | 0.00 | -5.00K | -11.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 28.77M | 29.66M | -10.13M | 37.70M | -9.19M |
| Cash from Investing | 28.69M | 29.66M | -10.13M | 37.70M | -9.20M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 0.00 | 0.00 | 0.00 | -739.00K |
| Issuance of Common Stock | 37.00K | 0.00 | 0.00 | 0.00 | 7.94M |
| Repurchase of Common Stock | -73.00K | -9.00K | 0.00 | 0.00 | -32.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | -42.00K | -128.00K | -60.00K |
| Cash from Financing | -36.00K | -9.00K | -42.00K | -128.00K | 7.11M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.47M | 2.44M | -34.77M | 21.03M | -19.96M |